rare disease unit

This page shows the latest rare disease unit news and features for those working in and with pharma, biotech and healthcare.

P&G agrees $4.2bn buy of Merck KGaA’s consumer health unit

P&G agrees $4.2bn buy of Merck KGaA’ s consumer health unit. ... In the last few weeks Sanofi has sold its European generics business to Advent, GlaxoSmithKline divested its rare disease unit to start-up Orchard Therapeutics after buying Novartis out

Latest news

GSK hands rare disease assets over to Orchard

GSK hands rare disease assets over to Orchard. The UK pharma group will take a 19.9% stake in its ex-rival. ... GlaxoSmithKline has decided the future of its rare disease business - and it lies outside the company.
Chiesi's ultra-rare genetic disorder therapy wins European backing

This aims to grant access for extremely rare disorder treatment when traditional large-scale clinical studies are not feasible. ... It’s the second most advanced product from Chiesi’s rare disease unit after its LSCD therapy Holoclar claimed
GSK’s R&D head Vallance departs, possibly for government role

Since taking over she has also stripped out a number of lower priority R&D programmes and products and placed GSK’s rare disease unit under a review to see if
NICE backs Europe's first stem cell therapy

LSCD is a rare condition that can lead to blindness, and affects just 3.3 out of 100, 000 people in the EU. ... Holoclar - which won the UK Prix Galien award in 2016 - is the first product from Chiesi's nine-year-old rare disease unit to reach the market,
Ionis must go it alone as GSK ditches polyneuropathy drug

GlaxoSmithKline has decided not to take an option on Ionis' inotersen for polyneuropathy, further evidence of GSK's retreat from the rare disease arena. ... Last week, the big pharma group said it was considering a sale of its rare disease unit as part

More from news
Approximately 1 fully matching, plus 20 partially matching documents found.

Latest from PMHub

Focus on Rare Diseases

Lucid’ s Rare Disease Business Unit currently works with clients in Fabry disease, Pompe disease, Gaucher disease, cystinosis and PKU. ... For further information about working with Lucid’ s Rare Disease Business Unit, please call Alison on 01494

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Manager / Account Director: Great salary and bebefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Medical Writer - (London, Brighton or Copenhagen): Competitive

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Senior Medical Writer: Great salary and benefits

Senior Account Manager or AD - Medical Communications: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior Programme Executive: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Scientific Director: Great salary and bebefits

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Medical Writer: Great salary and bebefits

Account Manager – Med Comms – London: Salary TBC

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

Pharma’s isolated islands of innovation: With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit: What does it mean for the life science sector?...
The Holy Grail of HCP Access: This is the data you need to gain access....